Company / Working Capital per Share
BeOne Medicines Ltd. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.17
FY2025
5-year range
$1.31 / $4.99
FY2021-FY2025
Trend
+142.9%
vs FY2024
Sector context
#138 of 210
Health Care
What the data says
At $3.17, BeOne Medicines Ltd.'s working capital per share ranks #138 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 3 years of decline, reaching $3.17.
Based on SEC 10-K filings.
3.17 in FY2025 with a 5-year CAGR of -8.1%.
Improved from $1.76 to $3.17 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
#138 of 210 in Health CareTop 66% of 210This company $3.17 Sector average $118.60
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 142.9% year-over-year.
- Ranks #138 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.17 | +142.9% |
| FY2024 | $1.31 | -25.9% |
| FY2023 | $1.76 | -37.0% |
| FY2022 | $2.80 | -43.8% |
| FY2021 | $4.99 | +2.8% |
| FY2020 | $4.85 | +336.5% |
| FY2019 | $1.11 | -61.2% |
| FY2018 | $2.87 | +93.7% |
| FY2017 | $1.48 | -49.3% |
| FY2016 | $2.92 | +354.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026